Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
3.670
+0.020 (0.55%)
At close: May 30, 2025, 4:00 PM
3.640
-0.030 (-0.82%)
After-hours: May 30, 2025, 7:53 PM EDT
Bionano Genomics Employees
As of December 31, 2024, Bionano Genomics had 100 total employees, including 98 full-time and 2 part-time employees. The number of employees decreased by 244 or -70.93% compared to the previous year.
Employees
100
Change (1Y)
-244
Growth (1Y)
-70.93%
Revenue / Employee
$284,640
Profits / Employee
-$836,970
Market Cap
11.04M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
BNGO News
- 11 days ago - Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders - GlobeNewsWire
- 16 days ago - Bionano Genomics, Inc. (BNGO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress - GlobeNewsWire
- 17 days ago - Bionano Laboratories Announces Publication of the Largest Study To-Date Evaluating Clinical Utility of Optical Genome Mapping Across Multiple Hematologic Malignancies - GlobeNewsWire
- 23 days ago - Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025 - GlobeNewsWire
- 4 weeks ago - International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers - GlobeNewsWire
- 5 weeks ago - Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease - GlobeNewsWire
- 7 weeks ago - Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM - GlobeNewsWire